← Back to Clinical Trials
Recruiting NCT06568289

Lignocaine vs Bupivacaine Infiltration for Postpartum Perineal Pain After Vaginal Delivery With Episiotomy in Primigravidae

Trial Parameters

Condition Lignocaine
Sponsor Ain Shams University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 60
Sex FEMALE
Min Age 18 Years
Max Age 40 Years
Start Date 2024-03-01
Completion 2024-09-01
Interventions
LignocaineBupivacaine

Brief Summary

In this study, we will compare the effect and safety of lignocaine versus bupivacaine infiltration for postpartum perineal pain after vaginal delivery with episiotomy in primigravidae.

Eligibility Criteria

Inclusion Criteria: * Primigravidae with the full term undergoing vaginal delivery with episiotomy. * Pregnancies and singleton vertex cephalic fetuses. * In the active phase of the first stage of labor. Exclusion Criteria: * Patients with history of drug allergies to study drugs as this will increase the risk of complications. * Patients undergoing vaginal delivery under epidural or spinal anesthesia as they will affect post-operative pain and interfere with assessment of efficacy of local infiltration of the study drugs. * Evidence of local infection at site of injection as this will interfere with the action of the study drug and will increase the risk of complications. * Inability to cooperate as this will affect our assessment. * Patient's refusal. * Any intraoperative complications that will affect our outcome criteria (bleeding, organ injury) as they will affect patient's vital data and affect our assessment. * Neurological comorbidities (chronic pain disorder, chronic systemic

Related Trials